Science
Mechanism of Action
These bacteriophages are species-specific viruses that precisely adhere to and degrade the peptidoglycan cell walls of Cutibacterium acnes bacteria through specialized endolysins. This action leads to the lysis of the host bacterial cell and the release of new phages, effectively reducing the C. acnes population. Their highly targeted nature ensures beneficial skin microbiota remains unharmed. Furthermore, these phages demonstrate the ability to penetrate bacterial biofilms and exhibit immunomodulatory properties, which contribute to a reduction in inflammatory responses associated with acne.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 An aqueous cetomacrogol cream formulated with 2.5 x 10^8 PFU/g of bacteriophages demonstrated effective lysis of C. acnes in agar cultures and maintained activity for at least 90 days when stored at 4 °C (Brown et al., 2016).
- 02 A 0.5% hydroxyethyl cellulose (HEC) cream containing 1 x 10^9 PFU/mL of phage TCUCAP1 retained its full lytic capacity against C. acnes for 180 days when stored at 4 °C (Tsai et al., 2021).
- 03 A topical gel comprising a three-phage cocktail (BX001) was proven safe, well-tolerated, and reduced the facial burden of C. acnes in a phase 1 cosmetic randomized clinical trial for mild-to-moderate acne (Golembo et al., 2022).
- 04 Bacteriophage PAP 1-1 at a concentration of 0.01 MOI effectively controlled the proliferation of C. acnes in RCM broth, with significant enhancement when combined with specific bacteriocins and nisin (Han et al., 2023).
Transparency
Dusting Analysis
As a biological agent measured in PFU (Plaque Forming Units), bacteriophages are not typically 'dusted' in formulations like chemical compounds.
The Formula
Formulation
Stability
Optimal stability for C. acnes bacteriophages is observed around pH 7, with activity effectively retained between pH 5 and 9. While demonstrating significant stability across a broader pH range (3–11) for short periods, efficacy can diminish notably at pH extremes over prolonged exposure. Long-term viability is best preserved at 4 °C in light-protected conditions, often extending activity for 90 to 180 days. Exposure to temperatures above 40-45 °C or direct light, especially at warmer temperatures, leads to substantial to complete loss of lytic capacity. Successful formulations include aqueous cetomacrogol creams, hydroxyethyl cellulose (HEC) gels, oil-base creams, and water-oil nanoemulsions.
Synergies
- Bacteriocins (e.g., from Lactococcus lactis CJNU 3001)
- Nisin
Conflicts
- Exposure to temperatures exceeding 40-45 °C
- Direct light exposure, particularly at warmer temperatures
- Sustained strongly acidic (e.g., pH 3) or strongly alkaline (e.g., pH 11) environments
- Lysogenic or temperate phages (preferred use of lytic phages to mitigate risks of gene transfer)
Safety
Safety Profile
Bacteriophages are generally considered to possess a robust safety profile due to their highly specific targeting of bacteria and inertness to mammalian cells. Preclinical evaluations indicate they are non-irritant to human skin or ocular tissues in ex vivo models and do not permeate through human epidermis. While some phages have received 'Generally Regarded as Safe' (GRAS) status from the FDA for food and plant protection, and FDA guidance for therapeutic use acknowledges their low toxicological risk, specific reviews by CIR or SCCS for cosmetic applications of Cutibacterium acnes bacteriophages are not currently available.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This highly targeted ingredient shows significant promise for precision acne treatment by specifically eliminating C. acnes bacteria while preserving beneficial skin microbiota.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources